| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
18,121 |
16,381 |
$1.34M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
14,329 |
12,219 |
$895K |
| 80053 |
Comprehensive metabolic panel |
15,384 |
12,170 |
$404K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,384 |
2,050 |
$307K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,129 |
4,183 |
$288K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,650 |
2,088 |
$287K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,051 |
1,912 |
$141K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
984 |
912 |
$81K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,158 |
2,584 |
$78K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
59 |
53 |
$67K |
| G0378 |
Hospital observation service, per hour |
3,415 |
1,614 |
$60K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
907 |
803 |
$55K |
| 71045 |
Radiologic examination, chest; single view |
8,822 |
7,537 |
$37K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
97 |
78 |
$36K |
| 87070 |
|
3,840 |
3,577 |
$34K |
| 87040 |
|
3,454 |
2,421 |
$29K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,997 |
5,537 |
$24K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
697 |
628 |
$22K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,996 |
3,452 |
$21K |
| 81025 |
|
3,772 |
3,461 |
$18K |
| 87275 |
|
6,718 |
6,334 |
$16K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,520 |
1,995 |
$16K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,628 |
5,253 |
$15K |
| S0028 |
Injection, famotidine, 20 mg |
813 |
664 |
$15K |
| 85027 |
|
20,585 |
15,871 |
$14K |
| 80076 |
|
1,426 |
1,328 |
$14K |
| 80047 |
|
621 |
542 |
$11K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,293 |
974 |
$10K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,368 |
7,089 |
$10K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,563 |
2,975 |
$9K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,086 |
1,843 |
$9K |
| A9270 |
Non-covered item or service |
7,116 |
1,314 |
$9K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
7,731 |
5,855 |
$8K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
846 |
673 |
$8K |
| 81001 |
|
4,702 |
4,112 |
$7K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
548 |
509 |
$6K |
| 81003 |
|
2,916 |
2,528 |
$5K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,002 |
435 |
$5K |
| 84702 |
|
1,169 |
1,015 |
$4K |
| 74018 |
|
632 |
568 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,841 |
3,650 |
$4K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
257 |
231 |
$3K |
| 87276 |
|
6,715 |
6,331 |
$3K |
| 73630 |
|
235 |
211 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,274 |
1,746 |
$3K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
15 |
14 |
$3K |
| 84484 |
|
4,497 |
3,023 |
$3K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
298 |
241 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
576 |
523 |
$2K |
| 85610 |
|
3,234 |
2,528 |
$2K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
157 |
116 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,470 |
2,870 |
$2K |
| 72100 |
|
252 |
226 |
$2K |
| 86900 |
|
1,224 |
1,031 |
$2K |
| 85730 |
|
3,135 |
2,471 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,233 |
2,466 |
$2K |
| 86901 |
|
1,217 |
1,028 |
$2K |
| 86885 |
|
457 |
363 |
$2K |
| 87210 |
|
125 |
116 |
$2K |
| 87076 |
|
524 |
424 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,663 |
3,139 |
$2K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
63 |
54 |
$1K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
15 |
14 |
$1K |
| 82550 |
|
2,670 |
2,015 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,484 |
923 |
$1K |
| 83690 |
|
3,395 |
2,948 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,564 |
1,304 |
$1K |
| 73610 |
|
139 |
130 |
$992.11 |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
30 |
13 |
$912.36 |
| 83605 |
|
2,431 |
1,887 |
$871.40 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
123 |
120 |
$864.69 |
| 82553 |
|
719 |
468 |
$863.39 |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,585 |
2,187 |
$748.11 |
| 73030 |
|
28 |
27 |
$711.65 |
| 73564 |
|
112 |
98 |
$697.52 |
| 76801 |
|
57 |
55 |
$674.84 |
| J1815 |
Injection, insulin, per 5 units |
198 |
59 |
$591.48 |
| 84703 |
|
1,244 |
1,133 |
$578.59 |
| 83880 |
|
1,179 |
941 |
$527.38 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
17 |
13 |
$523.49 |
| 86850 |
|
98 |
87 |
$486.01 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
225 |
130 |
$432.95 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
77 |
69 |
$426.20 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
66 |
55 |
$414.66 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
667 |
611 |
$398.04 |
| 73110 |
|
29 |
27 |
$394.32 |
| 87807 |
|
553 |
533 |
$382.85 |
| J2060 |
Injection, lorazepam, 2 mg |
788 |
579 |
$373.99 |
| 87186 |
|
517 |
397 |
$366.70 |
| 87205 |
|
306 |
186 |
$343.09 |
| 83735 |
|
388 |
299 |
$338.19 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,504 |
1,026 |
$326.93 |
| 73130 |
|
36 |
32 |
$309.57 |
| 85379 |
|
1,010 |
883 |
$305.96 |
| 80143 |
|
686 |
590 |
$214.21 |
| 73502 |
|
18 |
13 |
$199.22 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
159 |
115 |
$189.86 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
361 |
307 |
$136.98 |
| 82248 |
|
467 |
330 |
$124.04 |
| 82077 |
|
984 |
846 |
$115.60 |
| 72040 |
|
34 |
27 |
$104.06 |
| 90714 |
|
31 |
26 |
$85.00 |
| 80329 |
|
1,363 |
1,143 |
$70.86 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
128 |
111 |
$65.72 |
| 80320 |
|
701 |
662 |
$50.71 |
| 80061 |
Lipid panel |
98 |
84 |
$14.50 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
47 |
42 |
$3.15 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
93 |
85 |
$2.95 |
| 80306 |
|
29 |
28 |
$0.00 |
| 82247 |
|
79 |
73 |
$0.00 |
| 84155 |
|
79 |
73 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
14 |
14 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
76 |
65 |
$0.00 |
| 84460 |
|
79 |
73 |
$0.00 |
| 85007 |
|
39 |
39 |
$0.00 |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
347 |
49 |
$0.00 |
| 84450 |
|
79 |
73 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
79 |
74 |
$0.00 |
| J3490 |
Unclassified drugs |
39 |
28 |
$0.00 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
25 |
24 |
$0.00 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
133 |
87 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
552 |
451 |
$0.00 |
| 82040 |
|
79 |
73 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
37 |
26 |
$0.00 |
| 84075 |
|
79 |
73 |
$0.00 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
16 |
13 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
110 |
94 |
$0.00 |
| 96376 |
|
16 |
14 |
$0.00 |
| 86140 |
|
32 |
29 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
163 |
124 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
12 |
12 |
$0.00 |